WAVE LIFE SCIENCES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.66 USD | -1.69% |
|
-4.31% | -7.72% |
Chart calendar Wave Life Sciences Ltd.
afedc528ffe8af94.L04Jof6vfe54WeTlf2IeTxQCkioLHgoIelqwjcWkL0w.eSM-lMrnEqwNMomzJSFoekVAwhleZGU5AxPWwYP7VxVuJ0TImpkYhhQ2hw~2e136edcc60d576a5a28e95b05551bf2
Upcoming events on Wave Life Sciences Ltd.
Past events on Wave Life Sciences Ltd.
| 11/04/2024 13:45 | Needham Healthcare Conference |
| 03/04/2024 20:10 | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 06/03/2024 13:30 | Q4 2023 Earnings Call |
| 06/03/2024 12:30 | Q4 2023 Earnings Release |
| 04/03/2024 23:00 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #M168 |
| 03/03/2024 23:00 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S10 |
| 03/03/2024 23:00 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S14 |
| 10/01/2024 23:00 | JPMorgan Healthcare Conference |
| 29/11/2023 20:50 | Evercore ISI HealthCONx Conference |
| 09/11/2023 13:30 | Q3 2023 Earnings Call |
| 09/11/2023 12:30 | Q3 2023 Earnings Release |
| 02/10/2023 15:30 | Chardan Genetic Medicines Conference |
| 28/09/2023 15:00 | R&D Day |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 13:30 | Q2 2023 Earnings Call |
| 03/08/2023 12:30 | Q2 2023 Earnings Release |
| 31/07/2023 | Annual General Meeting |
| 23/05/2023 13:30 | FOCUS-C9 Phase 1b/2a Study Results Call |
| 18/05/2023 20:00 | American Society of Gene Cell Therapy Meeting - Poster Session No.: 1219 |
| 18/05/2023 00:45 | American Society of Gene & Cell Therapy Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,0 18,9 -15.62% | 20,1 20,5 -1.98% | 41,0 52,7 -22.27% | 3,65 4,80 -24.03% | 113 104 8.9% | 76,4 |
|
EBITDA Million USD | Released Forecast Spread | -199 -196 -1.61% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -208 -201 -3.68% | -153 -150 -2.26% | -127 -121 -5.11% | -163 -157 -3.4% | -68,0 -79,7 14.72% | -130 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -194 -188 -3.14% | -151 -148 -2.15% | -122 -117 -5.03% | -161 -156 -3.62% | -58,2 -70,9 17.97% | -122 |
|
Net income Million USD | Released Forecast Spread | -194 -188 -3.14% | -150 -148 -1.58% | -122 -115 -6.02% | -162 -156 -3.58% | -57,5 -65,3 11.91% | -119 |
|
EPS USD | Released Forecast Spread | -5,72 -5,53 -3.36% | -3,82 -3,84 0.62% | -2,36 -2,22 -6.17% | -2,05 -2,01 -1.91% | -0,54 -0,62 12.67% | -1,01 |
| Announcement Date | 02/03/20 | 04/03/21 | 03/03/22 | 22/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,77 15,8 -88.82% | 1,75 3,86 -54.63% | 0,38 3,00 -87.5% | 0,29 5,40 -94.72% | 1,24 2,40 -48.34% | 12,9 38,6 -66.51% | 22,1 7,94 178.5% | 49,2 23,4 110.03% | 29,1 19,8 46.56% | 22,9 | 19,6 | 16,9 | 16,9 | 15,0 |
|
EBIT Million USD | Released Forecast Spread | -36,1 -29,9 -20.7% | -38,1 -35,4 -7.68% | -42,2 -35,2 -19.62% | -38,9 -40,2 3.15% | -43,6 -38,2 -13.93% | -30,3 -1,35 -2147.08% | -23,5 -37,3 37.01% | 4,44 -24,9 117.83% | -18,7 -30,5 38.71% | -25,1 | -31,8 | -36,6 | -37,3 | -37,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,0 -29,2 -19.81% | -37,8 -34,4 -9.78% | -41,3 -34,5 -19.8% | -39,0 -39,4 0.92% | -43,0 -37,4 -14.97% | -27,4 -0,61 -4390.78% | -21,1 -36,0 41.45% | 6,58 -23,3 128.17% | -16,3 -29,0 43.93% | -23,1 | -29,8 | -34,6 | -35,3 | -35,9 |
|
Net income Million USD | Released Forecast Spread | -34,8 -27,9 -24.59% | -37,8 -33,4 -13.2% | -41,3 -33,8 -22.08% | -39,0 -39,2 0.43% | -43,7 -38,1 -14.61% | -27,4 -6,07 -351.62% | -21,1 -34,9 39.5% | 7,00 -18,9 137.11% | -16,3 -23,9 31.96% | -24,0 | -28,7 | -32,8 | -33,9 | -35,9 |
|
EPS USD | Released Forecast Spread | -0,61 -0,51 -19.61% | -0,62 -0,56 -11.71% | -0,62 -0,54 -15.17% | -0,42 -0,50 15.44% | -0,45 -0,41 -9.76% | -0,27 -0,04 -575% | -0,20 -0,33 39.66% | 0,07 -0,18 139.25% | -0,15 -0,23 33.82% | -0,21 | -0,24 | -0,27 | -0,28 | -0,28 |
| Announcement Date | 03/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 03/05/23 | 03/08/23 | 09/11/23 | 06/03/24 | - | - | - | - | - |
More events
Past sector events for Wave Life Sciences Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WVE Stock
- Calendar Wave Life Sciences Ltd.
